BACKGROUND: Recent findings in mouse models suggest that T helper (Th)17 cells, characterised by production of interleukin (IL)-17A and IL-22, are involved in the immunopathogenesis of pneumonia. OBJECTIVE: In this study, we aimed to identify the involvement of Th17 cells in human community-acquired pneumonia (CAP). DESIGN: Within 24 h of admission, T cells from peripheral blood (n=39) and bronchoalveolar lavage (BAL, n=20) of CAP patients and of 10 healthy individuals were analysed by intracellular flow cytometry for the production of various cytokines, including IL-17A and IL-22. Peripheral blood T cells were also analysed 7 and 30 days after admission. Th17 cytokine profiles were correlated with pneumonia severity index and microbial aetiology. RESULTS: In the BAL of CAP patients, proportions of IL-17A and IL-22 single positive, as well as IL-17A/IL-22 double positive CD4 T cells were significantly increased compared with healthy individuals. Significantly increased proportions of IL-17A/IL-22 double positive CD4 T cells in BAL were found in non-severe and severe CAP patients, as well as in pneumococcal and non-pneumococcal CAP. In the peripheral blood of CAP patients upon admission, we found significantly increased proportions of IL-17A/IL-22 double positive CD4 T cells. One week after admission, the proportions of these double positive cells were still significantly increased in CAP patients compared with healthy individuals. CONCLUSIONS: These data indicate that Th17 cells are engaged in the local and systemic immune response in human pneumonia. Especially, IL-17A/IL-22 double positive Th17 cells may be involved in the immunopathogenesis of CAP.
BACKGROUND: Recent findings in mouse models suggest that T helper (Th)17 cells, characterised by production of interleukin (IL)-17A and IL-22, are involved in the immunopathogenesis of pneumonia. OBJECTIVE: In this study, we aimed to identify the involvement of Th17 cells in human community-acquired pneumonia (CAP). DESIGN: Within 24 h of admission, T cells from peripheral blood (n=39) and bronchoalveolar lavage (BAL, n=20) of CAP patients and of 10 healthy individuals were analysed by intracellular flow cytometry for the production of various cytokines, including IL-17A and IL-22. Peripheral blood T cells were also analysed 7 and 30 days after admission. Th17 cytokine profiles were correlated with pneumonia severity index and microbial aetiology. RESULTS: In the BAL of CAP patients, proportions of IL-17A and IL-22 single positive, as well as IL-17A/IL-22 double positive CD4 T cells were significantly increased compared with healthy individuals. Significantly increased proportions of IL-17A/IL-22 double positive CD4 T cells in BAL were found in non-severe and severe CAP patients, as well as in pneumococcal and non-pneumococcal CAP. In the peripheral blood of CAP patients upon admission, we found significantly increased proportions of IL-17A/IL-22 double positive CD4 T cells. One week after admission, the proportions of these double positive cells were still significantly increased in CAP patients compared with healthy individuals. CONCLUSIONS: These data indicate that Th17 cells are engaged in the local and systemic immune response in humanpneumonia. Especially, IL-17A/IL-22 double positive Th17 cells may be involved in the immunopathogenesis of CAP.
Authors: Valerie R Stolberg; Alexandra L McCubbrey; Christine M Freeman; Jeanette P Brown; Sean W Crudgington; Sophina H Taitano; Bridget L Saxton; Peter Mancuso; Jeffrey L Curtis Journal: J Immunol Date: 2015-05-18 Impact factor: 5.422
Authors: R F Hannaway; X Wang; M Schneider; S Slow; J Cowan; B Brockway; M R Schofield; X C Morgan; D R Murdoch; J E Ussher Journal: Clin Exp Immunol Date: 2019-10-24 Impact factor: 4.330
Authors: Kristina Andelid; Sara Tengvall; Anders Andersson; Bettina Levänen; Karin Christenson; Pernilla Jirholt; Christina Åhrén; Ingemar Qvarfordt; Ann Ekberg-Jansson; Anders Lindén Journal: Int J Chron Obstruct Pulmon Dis Date: 2015-03-27
Authors: Amanda Tufman; Rudolf Maria Huber; Stefanie Völk; Frederic Aigner; Martin Edelmann; Fernando Gamarra; Rosemarie Kiefl; Kathrin Kahnert; Fei Tian; Anne-Laure Boulesteix; Stefan Endres; Sebastian Kobold Journal: BMC Cancer Date: 2016-07-07 Impact factor: 4.430
Authors: Olga Rajas; Mara Ortega-Gómez; José María Galván Román; José Curbelo; Guillermo Fernández Jiménez; Lorena Vega Piris; Francisco Rodríguez Salvanes; Belén Arnalich; Sergio Luquero Bueno; Ana Díaz López; Hortensia de la Fuente; Carmen Suárez; Julio Ancochea; Javier Aspa Journal: BMC Pulm Med Date: 2014-12-12 Impact factor: 3.317